Showing 1 - 7 results of 7 for search 'Biju George', query time: 0.01s Refine Results
  1. 1
    Dysregulation of Iron Homeostasis in β-Thalassemia and Impaired Neutrophil Activity

    Dysregulation of Iron Homeostasis in β-Thalassemia and Impaired Neutrophil Activity by Sreenithi Santhakumar, Leo Stephen, Aruna Barade, Uday Kulkarni, Biju George, Eunice S. Edison

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Jejunogastric Intussusception: An Unusual Cause of Hematemesis

    Jejunogastric Intussusception: An Unusual Cause of Hematemesis by Inian Samarasam, Sudhakar Chandran, Uday Shankar, Biju George, Ashok Chacko, George Mathew

    Published 2005-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Prevalence of β-thalassaemia trait among school-going children in Jawadhi Hills: A School-based cross-sectional study

    Prevalence of β-thalassaemia trait among school-going children in Jawadhi Hills: A School-based cross-sectional study by Sam M. David, Eunice Sindhuvi, Midhun Sasikumar, D. Beula, Anuradha Rose, Kuryan George, S. Shanthi, Biju George

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Therapeutic Versus Non‐Therapeutic Dose Anticoagulation in COVID‐19 Infection: A Systematic Review and Meta‐analysis of Randomised Controlled Trials

    Therapeutic Versus Non‐Therapeutic Dose Anticoagulation in COVID‐19 Infection: A Systematic Review and Meta‐analysis of Randomised Controlled Trials by Sushil Selvarajan, Jisha Sara John, Prathap Tharyan, Richard Kirubakaran, Bhagteshwar Singh, Biju George, Joseph L. Mathew, Priscilla Rupali

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide

    A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide by Uday Kulkarni, Saravanan Ganesan, Ansu Abu Alex, Hamenth Palani, Sachin David, Nithya Balasundaram, Arvind Venkatraman, Mani Thenmozhi, Lakshmanan Jeyaseelan, Anu Korula, Anup Devasia, Aby Abraham, Nancy Beryl Janet, Poonkuzhali Balasubramanian, Biju George, Vikram Mathews

    Published 2020-04-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trial

    Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trial by Hamenth Kumar Palani, Arun Kumar Arunachalam, Uday Kulkarni, Mohammed Yasar, Arvind Venkatraman, Swathy Palanikumar, Reeshma Nair Radhakrishnan, Majeela Solomon, Abirami Rajasekaran, Aniket Bankar, Phaneendra Venkateswara Rao Datari, Sushil Selvarajan, Anu Korula, Pradyot Dash, Dina Schneider, Louisa Wirthlin, Aby Abraham, Biju George, Vikram Mathews

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance.

    Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance. by Ezhilarasi Chendamarai, Saravanan Ganesan, Ansu Abu Alex, Vandana Kamath, Sukesh C Nair, Arun Jose Nellickal, Nancy Beryl Janet, Vivi Srivastava, Kavitha M Lakshmi, Auro Viswabandya, Aby Abraham, Mohammed Aiyaz, Nandita Mullapudi, Raja Mugasimangalam, Rose Ann Padua, Christine Chomienne, Mammen Chandy, Alok Srivastava, Biju George, Poonkuzhali Balasubramanian, Vikram Mathews

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: